McElhenny Sheffield Capital Management
McElhenny Sheffield Capital Management reported 90 stocks worth $431M in its 13F filing for Q3 2026, filed Nov 6, 2026. Its largest holdings are MSMR (27.8%), TQQQ (19.1%) and QQQ (16.4%). Compared with Q2 2026, the fund opened new positions in TQQQ, ITOT and IHE, added to MSMR, QQQ and NOBL, trimmed PM, ABBV and PEP and sold out of IEF, SGOV and HDV.
Latest filing: what McElhenny Sheffield Capital Management did in Q3 2026
vs Q2 2026Dollar changes use the share change at the quarter end price. New and sold out show the whole position.
Portfolio at a glance
share of reported value · Q3 2026Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 | ![]() MSMR ETF Ser Solutions | $120M | 27.8% | 3.5M | +72K (+2%) | 8 of 8 | |
| 2 | ![]() TQQQ Proshares TR | $82.3M | 19.1% | 1.1M | New position | 5 of 8 | |
| 3 | ![]() QQQ Invesco Qqq TR | $70.7M | 16.4% | 96K | +94K (+7602%) | 7 of 8 | |
| 4 | ![]() SPY Spdr S&P 500 ETF TR | $38.5M | 8.9% | 51K | No change | 8 of 8 | |
| 5 | ![]() NOBL Proshares S&P 500 Div Aristocrat ETF | $17.6M | 4.1% | 325K | +3,907 (+1%) | 8 of 8 | |
| 6 | ![]() ITOT Ishares TR | $16.9M | 3.9% | 101K | New position | 4 of 8 | |
| 7 | ![]() IHE Ishares U.s. Pharmaceuticals ETF | $13.2M | 3.1% | 131K | New position | 2 of 8 | |
| 8 | ![]() IWM Ishares TR | $12.9M | 3.0% | 46K | +46K (+5210%) | 8 of 8 | |
| 9 | ![]() AAPL Apple Inc | $5.9M | 1.4% | 18K | +674 (+4%) | 8 of 8 | |
| 10 | ![]() MSFT Microsoft Corp | $4.7M | 1.1% | 9,231 | +146 (+2%) | 8 of 8 |
Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q2 2026, gone in Q3 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
![]() IEF Ishares TR | $96.2M | 1M |
![]() SGOV Ishares TR | $55.1M | 547K |
![]() HDV Ishares Core | $17M | 621K |
![]() XOM Exxon Mobil Corp | $1.3M | 9,534 |
![]() MET Metlife Inc | $397K | 4,689 |
🔒 Free account: see all 30.
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q3 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Nov 6, 2026 | 13F-HR | Q3 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →McElhenny Sheffield Capital Management 13F FAQ
What does McElhenny Sheffield Capital Management own?
McElhenny Sheffield Capital Management reported 90 stocks worth $431M in its 13F filing for Q3 2026, filed Nov 6, 2026. Its largest holdings are MSMR (27.8%), TQQQ (19.1%) and QQQ (16.4%). The table above lists every position in the filing (the top 10 without an account).
What did McElhenny Sheffield Capital Management buy and sell in Q3 2026?
Compared with Q2 2026: 13 new positions, 45 added to, 16 trimmed and 31 sold out. New positions include TQQQ, ITOT and IHE. It sold all of IEF, SGOV and HDV.
When will McElhenny Sheffield Capital Management file its next 13F?
Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.
How much is McElhenny Sheffield Capital Management's portfolio worth?
The Q3 2026 filing reports $431M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.





















